Nature Cardiovascular Research, 2022 Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension Boucherat O., Yokokawa T., Krishna V. et al. Olink Explore 3072/384CVDPathophysiologyPatient StratificationPlasma | | | | |
Scientific Reports, 2022 A disturbed balance between blood complement protective factors (FH, ApoE) and common pathway effectors (C5a, TCC) in acute COVID-19 and during convalesce Laudanski K., Okeke T., Siddiq K. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Fluids and Barriers of the CNS, 2022 Posthemorrhagic hydrocephalus associates with elevated inflammation and CSF hypersecretion via activation of choroidal transporters Lolansen S., Rostgaard N., Barbuskaite D. et al. Olink Target 96NeurologyPathophysiologyCSF | | | | |
PROTEOMICS – Clinical Applications, 2022 Plasma biomarkers for systemic inflammation in COVID‐19 survivors Zhao J., Schank M., Wang L. et al. Olink Target 96Infectious DiseasesPatient StratificationPlasma | | | | |
Journal of Investigative Dermatology, 2022 Comparison of the Inflammatory Circuits in Psoriasis Vulgaris, Non‒Pustular Palmoplantar Psoriasis, and Palmoplantar Pustular Psoriasis Wang C., Haxhinasto S., Garcet S. et al. Olink Target 96Dermatological DiseasesPathophysiologySerum | | | | |
Rheumatology, 2022 Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression Szilagyi I., Vallerga C., Boer C. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |
Diabetologia, 2022 Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality Bao X., Xu B., Muhammad I. et al. Olink Target 96OncologyMetabolic DiseasesPatient StratificationPlasma | | | | |
Laboratory Investigation, 2022 High-throughput proteomics: a methodological mini-review Cui M., Cheng C., Zhang L. Wider Proteomics StudiesReview/editorial | | | | |
Frontiers in Cardiovascular Medicine, 2022 Increased inflammatory markers in adult patients born with an atrial septal defect Schram A., Sellmer A., Nyboe C. et al. Olink Target 96CVDPathophysiologySerum | | | | |
Frontiers in Immunology, 2022 Plasma protein profiling reveals dynamic immunomodulatory changes in multiple sclerosis patients during pregnancy Papapavlou Lingehed G., Hellberg S., Huang J. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Cardiovascular Research, 2022 Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation Pol, T., Hijazi et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
Cell Reports Medicine, 2022 Plaque characteristics and biomarkers predicting regression and progression of carotid atherosclerosis Khan F., Gonçalves I., Shore A. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
Clinical Lymphoma Myeloma and Leukemia, 2022 High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments Fernandez N., Perumal D., Rahman A. et al. OncologyPathophysiologyPatient Stratification | | | | |
Clinical Cancer Research, 2022 Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T19 Diorio C., Shraim R., Myers R. et al. Olink Explore 3072/384OncologyImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum | | | | |
The Lancet Digital Health, 2022 Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study Byeon S., Madugundu A., Garapati K. et al. Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma | | | | |
Cell Systems, 2022 Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity Ambikan A., Yang H., Krishnan S. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Osteoarthritis and Cartilage Open, 2022 Technical performance of a proximity extension assay inflammation biomarker panel with synovial fluid Struglics A., Larsson S., Lohmander L. et al. Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationSerumSynovial Fluid | | | | |
Osteoarthritis and Cartilage, 2022 The alarmins high mobility group box protein 1 and S100A8/A9 display different inflammatory profiles after acute knee injury Aulin C., Larsson S., Vogl T. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySynovial Fluid | | | | |
Scientific Reports, 2022 People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells van Eekeren L., Matzaraki V., Zhang Z. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
PLOS Computational Biology, 2022 ATRPred: A machine learning based tool for clinical decision making of anti-TNF treatment in rheumatoid arthritis patients Prasad B., McGeough C., Eakin A. et al. Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma | | | | |